RFP | June 13, 2022
Federal Government Announces Novel Drug and Medical Device Development Tools to Help Expedite Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (R41/R42 Clinical Trial Optional) Grant Funding
Restricted Content
You must be an Elite member to view this resource.